Once diagnosed with breast cancer, it is a constant whirlwind of information, appointments, new terms that you have never heard of, but honestly all I thought of was what does this all mean and WILL I NEED CHEMO?
I had a tumor, I had breast cancer, I wanted to know more. How big was it and what will my prognosis be? I wanted to know this now, today, the minute they told me I had breast cancer. After searching the net for hours I discovered that there are actually tests that can help us understand more about the uniqueness of our tumor , will you benefit from chemo and the risk of recurrence.
Seriously-this was amazing to me! I found this to be so cutting edge and found a test that provided it all called Mammaprint.
Mammaprint is an early-stage personalized breast cancer test that looks at the genes of YOUR tumor to guide treatment decisions. The test will result with either a low risk (your low benefit to chemo would outweigh the risk and long term side effects) or High Risk (chemo would benefit you to prevent cancer coming back).
It can also identify if extended hormone therapy is needed (Ultralow Risk). Mammaprint can be used on an early stage patient, regardless of age, ethnicity, upd to 3 positive lymph nodes, 5cm tumor or less, and is FDA cleared.